Back to Journals » OncoTargets and Therapy » Volume 6

Primary malignant fibrous histiocytoma of the breast: report of one case

Authors Liu C, Zhao Z, Qingfu zhang, Wu Y, Jin F

Received 23 December 2012

Accepted for publication 17 February 2013

Published 3 April 2013 Volume 2013:6 Pages 315—319


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Caigang Liu,1 Zuowei Zhao,1 Qingfu Zhang,2 Yunfei Wu,3 Feng Jin3

1Department of Breast Surgery, Second Hospital of Dalian Medical University, Dalian, People's Republic of China; 2Department of Pathology, First Hospital of China Medical University, Shenyang, People's Republic of China; 3Department of Breast Surgery, General Surgery, First Hospital of China Medical University, Shenyang, People's Republic of China.

Abstract: Seven years ago, a 48-year-old female patient discovered a painless tumor in her right breast simply by chance. In the next year, the tumor increased significantly in size. At this point, the patient received a tumor resection, which was misdiagnosed as a benign mesenchymal tissue-originated tumor. Unfortunately, the tumor recurred just 10 days after resection. We subsequently resected the recurrent lesion and confirmed primary breast malignant fibrous histiocytoma. The tumor began to exhibit an unprecedented, massive, and uncontrolled growth, ulcerating soon after the operation. Treatment of the patient was limited by time. After the patient received a cycle of chemotherapy, she died of cachexia with the emergence of multiorgan metastasis 2 months after the operation.

Keywords: breast, primary malignant fibrous histiocytoma, treatment, survival

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.